Plus, news about Ipsen, Exelixis, Innovent, Codexis, Crosswalk Therapeutics and J&J:
Yuhan licenses prostate cancer drug: The biotech will pay Seoul …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The regulatory gaps and potential health risks of artificial intelligence (AI)-driven wellness apps.
Researchers in Germany have developed a comprehensive fitness model that forecasts the evolution of SARS-CoV-2 by integrating genetic, epidemiological, and immunological data. The study emphasizes
Ultragenyx said Thursday afternoon that its gene therapy for a rare liver ailment, glycogen disease type 1A, succeeded in a Phase 3 trial, setting up